world-dermatologist-2017-scientifictracks

12 / 14

Page 34
Notes:
allied
academies
Dermatol Res Skin Care 2017 | Volume 1 Issue 1
World
Dermatologist Summit and Skin Care Expo
October 30-31, 2017 | Toronto, Canada
Attentiveness of dermatologists in the middle east for the practice psychodermatololgy
Ossama Tawakol Osman
Behavioral Sciences Pavilion, UAE
Background: Many dermatologic patients suffer from coupled
psychiatric symptoms. Proper treatment of these patients
requires parallel psychiatric care. The main objective of this
study was to assess awareness of Middle East dermatologists to
psychocutaneous medicine.
Methods: This study utilized a survey that was originally
developed for dermatologists in the Upsychodermatology’
describes the psychiatric aspects of skin diseases as well as the
dermatologic manifestations of psychiatric problems.
Results: 57 dermatologists from United Arab Emirates, Saudi
Arabia, Egypt, Kuwait, Iraq, Jordan and Lebanon completed
the survey. 49 (86%) reported clear understanding of the term
psychodermatololgy, nine (16%) were very comfortable in
diagnosing and treating these disorders, and 52 (91%) were
unaware of patient/family resources on psychodermatology
(e.g., association for psychoneurocutaneous Medicine of North
America, European Society for dermatology and psychiatry,
psychodermatology UK, and Japanese Society of Psychosomatic
Dermatology). Acne, alopecia, vitiligo, atopic dermatitis,
and psoriasis were common skin diagnoses coupled with
psychiatric manifestations. 13 (23%) dermatologists expressed
interest in attending educational activities on managing
psychodermatologic diseases.
Conclusion: Patientswhohadpsychocutaneousdisordersmight
not receive necessary care because of insufficient experience
in managing their problems. This survey supports the need
for incorporating formal training on psychodermatololgy in
postgraduate dermatology programs. There is also a need for
establishing dermatology–psychiatry limited states to assess
regional experience with psychodermatololgy disorders. The
reasons especially acquainted with managing the patients.
Speaker Biography
Ossama Tawakol Osman is certified in Psychiatry by the American Board of Psychiatry
and Neurology and has been elected a fellow of the American Psychiatric Association.
He completed residency training at SIU-in Illinois, USA and a research fellowship in
clinical psychopharmacology at the National Institute of Mental health (NIMH) in
Bethesda, Maryland. His academic career is focused on bridging clinical research and
practice through community clinical, research, and educational program development
and had an extensive and diverse international experience. At USF in Tampa, Florida
he developed the psychiatric research program at the Bay Pines VAMC. At SIU he
helped to develop the academic research program in developmental disabilities in
Illinois. At Mercer University in Georgia, he developed the mental health community-
wide programs in substance abuse, mental health and developmental disabilities. In
Saudi Arabia, he helped develop the substance abuse and addiction services for the
western region of the kingdom through his capacity as the Medical Director of Al-Amal
Hospital-Jeddah 1999-2004. In the UAE research activities emphasized epidemiologic
community studies in the primary care and interdisciplinary clinical outcomes
research. Organizational involvement is a past president of American-Arab Psychiatric
Association, Member of scientific/executive councils for the Arab Board of Psychiatry
and Chairperson for its Committee on Curriculum/Accreditation/Credentialing.
e: